Furthermore, it is reported that intra-tumour injection of peptides may enhance tumour cell antigenicity in cancer immunotherapy.26 To sum up, targeting strategies should be developed to make ABH3 selective. The gene discussed is ALKBH3; the disease is neoplasm.